semaglutide discontinued A) Dose‐titration patterns and (B) discontinuation of for Oral Semaglutide Gets FDA Approval

rapid weight loss itself (not semaglutide specifically) can increase gallstone risk

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

Creatinine-based equations for the adjustment of drug dosage in an obese population

Glucagon-like peptide-1 (GLP-1) drugs help people lose weight by making them feel fuller with less food and by signaling the brain that the stomach contains food, reducing their appetite and cravings

GLP-1s may offer a dual benefit for patients with chronic conditions like diabetes or obesity who are also struggling with a substance use disorder: one medication can treat both conditions at once, Al-Aly said

This process is more obvious in the young and lean than in the old and obese, and in women rather than in men (Farmer, Effects of leptin on pancreatic -cells LepRs are present in pancreatic -cells, and leptin inhibits insulin biosynthesis and secretion from pancreatic -cells